CorVel Co. (CRVL) Chairman Sells $114,772.50 in Stock

CorVel Co. (NASDAQ:CRVL) Chairman V Gordon Clemons sold 2,250 shares of CorVel stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $51.01, for a total transaction of $114,772.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

V Gordon Clemons also recently made the following trade(s):

  • On Friday, June 15th, V Gordon Clemons sold 750 shares of CorVel stock. The shares were sold at an average price of $51.05, for a total transaction of $38,287.50.
  • On Monday, June 11th, V Gordon Clemons sold 5,000 shares of CorVel stock. The shares were sold at an average price of $50.51, for a total transaction of $252,550.00.
  • On Wednesday, June 13th, V Gordon Clemons sold 6,500 shares of CorVel stock. The shares were sold at an average price of $50.52, for a total transaction of $328,380.00.
  • On Wednesday, June 6th, V Gordon Clemons sold 5,000 shares of CorVel stock. The shares were sold at an average price of $51.59, for a total transaction of $257,950.00.

CorVel opened at $54.45 on Thursday, MarketBeat.com reports. The company has a market capitalization of $1.01 billion, a PE ratio of 28.48 and a beta of 0.68. CorVel Co. has a 1 year low of $44.81 and a 1 year high of $61.20.



CorVel (NASDAQ:CRVL) last posted its earnings results on Thursday, May 31st. The business services provider reported $0.47 earnings per share (EPS) for the quarter. The company had revenue of $143.57 million for the quarter. CorVel had a return on equity of 23.11% and a net margin of 6.39%.

Several hedge funds and other institutional investors have recently modified their holdings of CRVL. Matarin Capital Management LLC bought a new stake in shares of CorVel during the first quarter valued at about $2,976,000. First Trust Advisors LP bought a new stake in shares of CorVel during the fourth quarter valued at about $2,226,000. BlackRock Inc. raised its stake in shares of CorVel by 3.0% during the first quarter. BlackRock Inc. now owns 1,339,737 shares of the business services provider’s stock valued at $67,724,000 after purchasing an additional 38,632 shares in the last quarter. Guggenheim Capital LLC bought a new stake in shares of CorVel during the fourth quarter valued at about $1,520,000. Finally, Ancora Advisors LLC raised its stake in shares of CorVel by 17.7% during the first quarter. Ancora Advisors LLC now owns 109,939 shares of the business services provider’s stock valued at $5,557,000 after purchasing an additional 16,529 shares in the last quarter. Institutional investors and hedge funds own 43.83% of the company’s stock.

Separately, BidaskClub downgraded shares of CorVel from a “buy” rating to a “hold” rating in a research note on Wednesday, March 28th.

CorVel Company Profile

CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply